Gene symbol: Pla2g5

Also known as: PLA2-10

Organism: Rattus norvegicus

Summary: Enables calcium-dependent phospholipase A2 activity and heparin binding activity. Involved in several processes, including arachidonic acid secretion; leukotriene biosynthetic process; and platelet activating factor biosynthetic process. Located in Golgi apparatus; perinuclear region of cytoplasm; and plasma membrane. Human ortholog(s) of this gene implicated in familial benign fleck retina. Orthologous to human PLA2G5 (phospholipase A2 group V). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 29354 Ensembl:ENSRNOG00000016838 AllianceGenome:RGD:62051


GO Annotation


Category Term ID Term description
Process GO:0001845 Phagolysosome assembly
Process GO:0002682 Regulation of immune system process
Process GO:0002684 Positive regulation of immune system process
Process GO:0002694 Regulation of leukocyte activation
Process GO:0002697 Regulation of immune effector process
Process GO:0002699 Positive regulation of immune effector process
Process GO:0002831 Regulation of response to biotic stimulus
Process GO:0002833 Positive regulation of response to biotic stimulus
Process GO:0006082 Organic acid metabolic process
Process GO:0006629 Lipid metabolic process
Process GO:0006631 Fatty acid metabolic process
Process GO:0006644 Phospholipid metabolic process
Process GO:0006650 Glycerophospholipid metabolic process
Process GO:0006662 Glycerol ether metabolic process
Process GO:0006663 Platelet activating factor biosynthetic process
Process GO:0006690 Icosanoid metabolic process
Process GO:0006691 Leukotriene metabolic process
Process GO:0006793 Phosphorus metabolic process
Process GO:0006796 Phosphate-containing compound metabolic process
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006810 Transport
Process GO:0006811 Ion transport
Process GO:0006820 Anion transport
Process GO:0006869 Lipid transport
Process GO:0006906 Vesicle fusion
Process GO:0006909 Phagocytosis
Process GO:0006996 Organelle organization
Process GO:0007033 Vacuole organization
Process GO:0007040 Lysosome organization
Process GO:0008152 Metabolic process
Process GO:0008610 Lipid biosynthetic process
Process GO:0008611 Ether lipid biosynthetic process
Process GO:0008654 Phospholipid biosynthetic process
Process GO:0009056 Catabolic process
Process GO:0009058 Biosynthetic process
Process GO:0009395 Phospholipid catabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010033 Response to organic substance
Process GO:0010243 Response to organonitrogen compound
Process GO:0010517 Regulation of phospholipase activity
Process GO:0010518 Positive regulation of phospholipase activity
Process GO:0010638 Positive regulation of organelle organization
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010743 Regulation of macrophage derived foam cell differentiation
Process GO:0010744 Positive regulation of macrophage derived foam cell differentiation
Process GO:0010876 Lipid localization
Process GO:0014070 Response to organic cyclic compound
Process GO:0014074 Response to purine-containing compound
Process GO:0015711 Organic anion transport
Process GO:0015718 Monocarboxylic acid transport
Process GO:0015849 Organic acid transport
Process GO:0015908 Fatty acid transport
Process GO:0015909 Long-chain fatty acid transport
Process GO:0016042 Lipid catabolic process
Process GO:0016043 Cellular component organization
Process GO:0016050 Vesicle organization
Process GO:0016053 Organic acid biosynthetic process
Process GO:0016192 Vesicle-mediated transport
Process GO:0018904 Ether metabolic process
Process GO:0019370 Leukotriene biosynthetic process
Process GO:0019637 Organophosphate metabolic process
Process GO:0019752 Carboxylic acid metabolic process
Process GO:0022607 Cellular component assembly
Process GO:0023051 Regulation of signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0031347 Regulation of defense response
Process GO:0031348 Negative regulation of defense response
Process GO:0031349 Positive regulation of defense response
Process GO:0032048 Cardiolipin metabolic process
Process GO:0032101 Regulation of response to external stimulus
Process GO:0032102 Negative regulation of response to external stimulus
Process GO:0032103 Positive regulation of response to external stimulus
Process GO:0032309 Icosanoid secretion
Process GO:0032501 Multicellular organismal process
Process GO:0032787 Monocarboxylic acid metabolic process
Process GO:0032879 Regulation of localization
Process GO:0033036 Macromolecule localization
Process GO:0033043 Regulation of organelle organization
Process GO:0034097 Response to cytokine
Process GO:0034367 Protein-containing complex remodeling
Process GO:0034368 Protein-lipid complex remodeling
Process GO:0034369 Plasma lipoprotein particle remodeling
Process GO:0034374 Low-density lipoprotein particle remodeling
Process GO:0034638 Phosphatidylcholine catabolic process
Process GO:0035965 Cardiolipin acyl-chain remodeling
Process GO:0042221 Response to chemical
Process GO:0043030 Regulation of macrophage activation
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043408 Regulation of MAPK cascade
Process GO:0043410 Positive regulation of MAPK cascade
Process GO:0043436 Oxoacid metabolic process
Process GO:0043933 Protein-containing complex organization
Process GO:0044085 Cellular component biogenesis
Process GO:0044093 Positive regulation of molecular function
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0044242 Cellular lipid catabolic process
Process GO:0044248 Cellular catabolic process
Process GO:0044249 Cellular biosynthetic process
Process GO:0044255 Cellular lipid metabolic process
Process GO:0044281 Small molecule metabolic process
Process GO:0044283 Small molecule biosynthetic process
Process GO:0045017 Glycerolipid biosynthetic process
Process GO:0045088 Regulation of innate immune response
Process GO:0045089 Positive regulation of innate immune response
Process GO:0045595 Regulation of cell differentiation
Process GO:0045597 Positive regulation of cell differentiation
Process GO:0046394 Carboxylic acid biosynthetic process
Process GO:0046434 Organophosphate catabolic process
Process GO:0046456 Icosanoid biosynthetic process
Process GO:0046469 Platelet activating factor metabolic process
Process GO:0046470 Phosphatidylcholine metabolic process
Process GO:0046471 Phosphatidylglycerol metabolic process
Process GO:0046474 Glycerophospholipid biosynthetic process
Process GO:0046475 Glycerophospholipid catabolic process
Process GO:0046485 Ether lipid metabolic process
Process GO:0046486 Glycerolipid metabolic process
Process GO:0046503 Glycerolipid catabolic process
Process GO:0046504 Glycerol ether biosynthetic process
Process GO:0046683 Response to organophosphorus
Process GO:0046903 Secretion
Process GO:0046942 Carboxylic acid transport
Process GO:0048284 Organelle fusion
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048585 Negative regulation of response to stimulus
Process GO:0050482 Arachidonic acid secretion
Process GO:0050727 Regulation of inflammatory response
Process GO:0050728 Negative regulation of inflammatory response
Process GO:0050764 Regulation of phagocytosis
Process GO:0050766 Positive regulation of phagocytosis
Process GO:0050776 Regulation of immune response
Process GO:0050778 Positive regulation of immune response
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050865 Regulation of cell activation
Process GO:0050896 Response to stimulus
Process GO:0051049 Regulation of transport
Process GO:0051050 Positive regulation of transport
Process GO:0051094 Positive regulation of developmental process
Process GO:0051128 Regulation of cellular component organization
Process GO:0051130 Positive regulation of cellular component organization
Process GO:0051179 Localization
Process GO:0051234 Establishment of localization
Process GO:0051336 Regulation of hydrolase activity
Process GO:0051345 Positive regulation of hydrolase activity
Process GO:0051591 Response to cAMP
Process GO:0060191 Regulation of lipase activity
Process GO:0060193 Positive regulation of lipase activity
Process GO:0060627 Regulation of vesicle-mediated transport
Process GO:0061024 Membrane organization
Process GO:0061025 Membrane fusion
Process GO:0065007 Biological regulation
Process GO:0065009 Regulation of molecular function
Process GO:0070372 Regulation of ERK1 and ERK2 cascade
Process GO:0070374 Positive regulation of ERK1 and ERK2 cascade
Process GO:0070925 Organelle assembly
Process GO:0071702 Organic substance transport
Process GO:0071704 Organic substance metabolic process
Process GO:0071715 Icosanoid transport
Process GO:0071825 Protein-lipid complex subunit organization
Process GO:0071827 Plasma lipoprotein particle organization
Process GO:0071840 Cellular component organization or biogenesis
Process GO:0080134 Regulation of response to stress
Process GO:0080171 Lytic vacuole organization
Process GO:0090174 Organelle membrane fusion
Process GO:0090264 Regulation of immune complex clearance by monocytes and macrophages
Process GO:0090265 Positive regulation of immune complex clearance by monocytes and macrophages
Process GO:0090382 Phagosome maturation
Process GO:0090385 Phagosome-lysosome fusion
Process GO:0090407 Organophosphate biosynthetic process
Process GO:0097006 Regulation of plasma lipoprotein particle levels
Process GO:0097384 Cellular lipid biosynthetic process
Process GO:1900150 Regulation of defense response to fungus
Process GO:1901503 Ether biosynthetic process
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901565 Organonitrogen compound catabolic process
Process GO:1901566 Organonitrogen compound biosynthetic process
Process GO:1901575 Organic substance catabolic process
Process GO:1901576 Organic substance biosynthetic process
Process GO:1901698 Response to nitrogen compound
Process GO:1901700 Response to oxygen-containing compound
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902533 Positive regulation of intracellular signal transduction
Process GO:1903027 Regulation of opsonization
Process GO:1903028 Positive regulation of opsonization
Process GO:1903963 Arachidonate transport
Process GO:1905034 Regulation of antifungal innate immune response
Process GO:1905036 Positive regulation of antifungal innate immune response
Process GO:1905162 Regulation of phagosome maturation
Process GO:1905164 Positive regulation of phagosome maturation
Component GO:0000323 Lytic vacuole
Component GO:0005576 Extracellular region
Component GO:0005622 Intracellular anatomical structure
Component GO:0005737 Cytoplasm
Component GO:0005764 Lysosome
Component GO:0005767 Secondary lysosome
Component GO:0005768 Endosome
Component GO:0005773 Vacuole
Component GO:0005794 Golgi apparatus
Component GO:0005886 Plasma membrane
Component GO:0009986 Cell surface
Component GO:0012505 Endomembrane system
Component GO:0016020 Membrane
Component GO:0030139 Endocytic vesicle
Component GO:0031410 Cytoplasmic vesicle
Component GO:0031982 Vesicle
Component GO:0032009 Early phagosome
Component GO:0032010 Phagolysosome
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0045335 Phagocytic vesicle
Component GO:0048471 Perinuclear region of cytoplasm
Component GO:0055037 Recycling endosome
Component GO:0071944 Cell periphery
Component GO:0097708 Intracellular vesicle
Component GO:0110165 Cellular anatomical entity
Function GO:0003824 Catalytic activity
Function GO:0004620 Phospholipase activity
Function GO:0004623 Phospholipase A2 activity
Function GO:0005102 Signaling receptor binding
Function GO:0005488 Binding
Function GO:0005509 Calcium ion binding
Function GO:0005515 Protein binding
Function GO:0005539 Glycosaminoglycan binding
Function GO:0005543 Phospholipid binding
Function GO:0008201 Heparin binding
Function GO:0008289 Lipid binding
Function GO:0016298 Lipase activity
Function GO:0016787 Hydrolase activity
Function GO:0016788 Hydrolase activity, acting on ester bonds
Function GO:0043167 Ion binding
Function GO:0043169 Cation binding
Function GO:0046872 Metal ion binding
Function GO:0047498 Calcium-dependent phospholipase A2 activity
Function GO:0047499 Calcium-independent phospholipase A2 activity
Function GO:0052689 Carboxylic ester hydrolase activity
Function GO:0097367 Carbohydrate derivative binding
Function GO:1901681 Sulfur compound binding

Pathway annotation


Category Term ID Term description
RCTM RNO-1430728 Metabolism
RCTM RNO-1482788 Acyl chain remodelling of PC
RCTM RNO-1482801 Acyl chain remodelling of PS
RCTM RNO-1482839 Acyl chain remodelling of PE
RCTM RNO-1482922 Acyl chain remodelling of PI
RCTM RNO-1482925 Acyl chain remodelling of PG
RCTM RNO-1483166 Synthesis of PA
RCTM RNO-1483206 Glycerophospholipid biosynthesis
RCTM RNO-1483257 Phospholipid metabolism
RCTM RNO-556833 Metabolism of lipids
WikiPathways WP2433 Spinal cord injury
KEGG rno00564 Glycerophospholipid metabolism
KEGG rno00565 Ether lipid metabolism
KEGG rno00590 Arachidonic acid metabolism
KEGG rno00591 Linoleic acid metabolism
KEGG rno00592 alpha-Linolenic acid metabolism
KEGG rno01100 Metabolic pathways
KEGG rno04014 Ras signaling pathway
KEGG rno04270 Vascular smooth muscle contraction
KEGG rno04972 Pancreatic secretion
KEGG rno04975 Fat digestion and absorption

Expression profile of Pla2g5 in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 10.188284
GSM2685202 MX2 tissue: Myocardium gender: female 10.214468
GSM2685203 MX3 tissue: Myocardium gender: female 10.090984
GSM2685204 MX4 tissue: Myocardium gender: male 10.370247
GSM2685205 DZ1 tissue: Myocardium gender: male 9.818185
GSM2685206 DZ2 tissue: Myocardium gender: male 10.321237
GSM2685207 DZ3 tissue: Myocardium gender: female 10.302815
GSM2685208 DZ4 tissue: Myocardium gender: female 10.263685
GSM2685209 JJ1 tissue: Myocardium gender: male 9.900931
GSM2685210 JJ2 tissue: Myocardium gender: female 9.702068
GSM2685211 JJ3 tissue: Myocardium gender: female 9.263517
GSM2685212 JJ4 tissue: Myocardium gender: male 9.4177885
GSM2685213 NG1 tissue: Myocardium gender: male 9.52723
GSM2685214 NG2 tissue: Myocardium gender: female 10.052777
GSM2685215 NG3 tissue: Myocardium gender: male 9.482353
GSM2685216 NG4 tissue: Myocardium gender: female 9.56513
GSM2685217 YL1 tissue: Myocardium gender: male 9.966849
GSM2685218 YL2 tissue: Myocardium gender: male 9.699179
GSM2685219 YL3 tissue: Myocardium gender: female 9.55408
GSM2685220 YL4 tissue: Myocardium gender: female 9.52972
GSM2685221 QC1 tissue: Myocardium gender: male 9.837738
GSM2685222 QC2 tissue: Myocardium gender: male 9.972662
GSM2685223 QC3 tissue: Myocardium gender: female 9.738174
GSM2685224 QC4 tissue: Myocardium gender: female 9.669257

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.521525065
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.65366905
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.508955295
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.026661441
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.437387022
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 3.51305914

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 0.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 1.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 0.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 4.918899
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.055211
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 5.013555
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 5.362332
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 4.909114
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 4.832318

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 0.955
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 1.606
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 1.503
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 1.135
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 1.418

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 7.398198788
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 7.774900383
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 7.628578101

ID GSE1616
Title Genomics of preconditioning
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM27484 APC_a (anesthetic-preconditioning, 1st replicate) 340.0
GSM27485 APC_b (anesthetic-preconditioning, 2nd replicate) 355.9666666666667
GSM27486 APC_c (anesthetic-preconditioning, 3rd replicate) 362.3666666666666
GSM27487 APC_d (anesthetic-preconditioning, 4th replicate) 399.8333333333333
GSM27488 APC_e (anesthetic-preconditioning, 5th replicate) 417.43333333333334
GSM27489 APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) 378.09999999999997
GSM27490 APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) 325.1666666666667
GSM27491 APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) 281.3666666666667
GSM27492 APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) 273.93333333333334
GSM27493 APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) 291.09999999999997
GSM27494 CTL_a (control, 1st replicate) 412.8
GSM27495 CTL_b (control, 2nd replicate) 385.2
GSM27496 CTL_c (control, 3rd replicate) 390.9666666666667
GSM27497 CTL_d (control, 4th replicate) 365.3
GSM27498 CTL_e (control, 5th replicate) 360.4666666666667
GSM27499 IPC_a (ischemic preconditioning, 1st replicate) 370.8333333333333
GSM27500 IPC_b (ischemic preconditioning, 2nd replicate) 402.43333333333334
GSM27501 IPC_c (ischemic preconditioning, 3rd replicate) 391.6666666666667
GSM27502 IPC_d (ischemic preconditioning, 4th replicate) 406.06666666666666
GSM27503 IPC_e (ischemic preconditioning, 5th replicate) 323.23333333333335
GSM27504 IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) 378.26666666666665
GSM27505 IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) 225.9
GSM27506 IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) 382.1666666666667
GSM27507 IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) 370.3
GSM27508 IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) 430.40000000000003
GSM27509 ISCH_a (ischemia, 1st replicate) 303.03333333333336
GSM27510 ISCH_b (ischemia, 2nd replicate) 270.2333333333333
GSM27511 ISCH_c (ischemia, 3rd replicate) 164.83333333333334
GSM27512 ISCH_d (ischemia, 4th replicate) 353.06666666666666
GSM27513 ISCH_e (ischemia, 5th replicate) 256.3666666666667

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 463.4
GSM30791 baseline control 02 male, 275-300g 204.2
GSM30792 baseline control 03 male, 275-300g 145.0
GSM30793 baseline control 04 male, 275-300g 159.4
GSM30794 baseline control 05 male, 275-300g 124.6
GSM30795 baseline control 06 male, 275-300g 139.3
GSM30796 baseline control 07 male, 275-300g 159.7
GSM30797 baseline control 08 male, 275-300g 171.2
GSM30798 baseline control 09 male, 275-300g 243.1
GSM30799 pain 01 174.6
GSM30800 pain 02 203.6
GSM30801 pain 03 398.3
GSM30802 pain 04 167.2
GSM30803 pain 05 188.4
GSM30804 FC 01 176.5
GSM30805 FC 02 218.1
GSM30806 FC 03 206.4
GSM30807 FC 04 179.3
GSM30808 FC 05 128.8
GSM30809 IFC 01 159.3
GSM30810 IFC 02 164.8
GSM30811 IFC 03 161.0
GSM30812 IFC 04 161.1
GSM30813 IFC 05 154.1
GSM99800 isoflurane 01 male, 275-300g 174.4
GSM99801 isoflurane 02 male, 275-300g 186.7
GSM99802 isoflurane 03 male, 275-300g 177.0
GSM99803 isoflurane 04 male, 275-300g 181.2
GSM99804 isoflurane 05 male, 275-300g 170.3

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 17.9946
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 7.1067
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 8.3626
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 10.7682
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 8.686
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 6.2068
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 12.8866
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 13.0822
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 7.0366

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 4.59075
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 3.92249
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 4.67167
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 4.5869
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 3.48858
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 4.15705
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 5.16022
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 4.49426
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 4.56576
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 4.7652
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 5.14443
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 4.70143
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 4.58001
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 4.72792
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 4.74765
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 5.24225

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 5.944568
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 6.120619
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 6.019507
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 6.050096
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 6.162356
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.111809
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.094098
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.064017
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.232631
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 5.912673
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.014261
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.005437
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.043678
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.033711
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.071361
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 6.078321
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 6.068949
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 6.161603
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 6.171275
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 6.00484
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.993353
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 6.071144
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 6.192222
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 6.172001
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 5.919905
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 5.918736
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.208803
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.156738
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.094002
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.19057
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 6.116784
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 6.201473
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 6.094684
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 6.013838
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 6.454308
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.023968
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.174461
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.187396
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.077899
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.069866
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 6.427652
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 6.333168
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 6.399386
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 6.292169
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 6.439943

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 6.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 11.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 9.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 3.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 10.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 6.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 6.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 4.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 10.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 6.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 9.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 7.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 10.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 5.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 9.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 8.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 4.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 7.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 6.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 9.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 2.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 10.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 8.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 3.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 12.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 5.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 12.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 7.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 6.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 9.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 5.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 10.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 7.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 7.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 12.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 4.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 0.031151
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 0.0
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 0.0
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 0.0

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; -0.00476
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 0.0497
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 0.271
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 0.262
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 0.109
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 0.116
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 -0.0572
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 0.146
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 0.126
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 0.23
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 0.0577
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 0.0469

ID GSE359
Title Isoflurane Single Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5120 Isoflurane single exposure control-1 10.033333333333333
GSM5121 Isoflurane single exposure control-2 9.1
GSM5122 Isoflurane single exposure control-3 13.333333333333334
GSM5124 Isoflurane single exposure 1 hr-1 24.266666666666666
GSM5126 Isoflurane single exposure 1 hr-2 14.266666666666666
GSM5127 Isoflurane single exposure 2 hr-1 9.9
GSM5130 Isoflurane single exposure 2 hr-2 11.833333333333334
GSM5131 Isoflurane single exposure 2 hr-3 23.63333333333333

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 4.108661141
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 4.193708854
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.177073632
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.091860598
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.860473281
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 4.44845786
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.75564844
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.087807038
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 4.044006612
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.992704739
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 4.271166126
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 4.256497007
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.373626108
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.234869127
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.895460046
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 4.035090663
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.556063452
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.432856264
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 4.502910425
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 4.082422995
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 4.077626882
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 4.349090043
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.102542869
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.272987124

ID GSE53897
Title Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1303240 DRG RVM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.136226
GSM1303241 DRG RVM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.38676
GSM1303242 DRG RVM3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.161669
GSM1303243 DRG RVM7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.448399
GSM1303244 DRG RVOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.609349
GSM1303245 DRG RVOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.235896
GSM1303246 DRG RVOx5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.309599
GSM1303247 DRG RVOx7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.012209
GSM1303248 DRG RVS4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.154927
GSM1303249 DRG RVS5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.626298
GSM1303250 DRG RVS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.396788
GSM1303251 DRG RVS7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.854093
GSM1303252 DRG RSM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.67605
GSM1303253 DRG RSM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.183608
GSM1303254 DRG RSM4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.42252
GSM1303255 DRG RSM5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.275094
GSM1303256 DRG RSOx1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.646413
GSM1303257 DRG RSOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.269913
GSM1303258 DRG RSOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.277512
GSM1303259 DRG RSOx4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.920125
GSM1303260 DRG RSS1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.49953
GSM1303261 DRG RSS2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.318457
GSM1303262 DRG RSS3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.309599
GSM1303263 DRG RSS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 7.152237

ID GSE55573
Title Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1339443 Mock skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 144.4246
GSM1339444 EA (electroacupuncture) skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 170.6918

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 93.28340979
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 68.94359197
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 142.1107491
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 51.40965381
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 84.68088487
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 87.27115821
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 48.10274498
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 50.60019163
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 70.72812507
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 80.7468661
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 31.79049691
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 63.29138112
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 67.95747559
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 10.22171756

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 4.108661141
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 4.193708854
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.177073632
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 4.091860598
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 3.860473281
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 4.44845786
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.75564844
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 4.087807038
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 4.044006612
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 3.992704739
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 4.271166126
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 4.256497007
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.373626108
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 4.234869127
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 3.895460046
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 4.035090663
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.556063452
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 4.432856264
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 4.502910425
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 4.082422995
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 4.077626882
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 4.349090043
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.102542869
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 4.272987124
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 93.28340979
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 68.94359197
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 142.1107491
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 51.40965381
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 84.68088487
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 87.27115821
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 48.10274498
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 50.60019163
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 70.72812507
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 80.7468661
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 31.79049691
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 63.29138112
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 67.95747559
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 10.22171756

ID GSE752
Title Halothane/Isoflurane Repetitive Exposures
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5082 Control 1 12.200000000000001
GSM5084 Control 2 15.666666666666666
GSM5085 Control 3 10.1
GSM5086 Control 4 14.299999999999999
GSM5087 Control 5 19.8
GSM5090 Control 6 18.7
GSM5105 Control 7 12.233333333333334
GSM5106 Control 8 19.633333333333333
GSM5107 Control 9 12.166666666666666
GSM5108 Halothane 10 exposure-1 15.6
GSM5109 Halothane 10 exposures-2 12.966666666666669
GSM5110 Halothane 10 exposures-3 12.666666666666666
GSM5111 Halothane 5 exposures-1 17.966666666666665
GSM5112 Halothane 5 exposures-2 13.066666666666668
GSM5113 Halothane 5 exposures-3 11.200000000000001
GSM5114 Isoflurane 10 exposures-1 8.0
GSM5115 Isoflurane 10 exposures-2 22.366666666666664
GSM5116 Isoflurane 10 exposures-3 13.566666666666668
GSM5117 Isoflurane 5 exposures-1 15.433333333333332
GSM5118 Isoflurane 5 exposures-2 13.033333333333331
GSM5119 Isoflurane 5 exposures-3 9.666666666666666
GSM11379 Control 10 15.299999999999999
GSM11380 Control 11 28.23333333333333
GSM11381 Control 12 20.166666666666668

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 17.9209
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 20.3604